Clinical Trial Details
| Trial ID: | L0546 |
| Source ID: | NCT00235287 |
| Associated Drug: | Candesartan And Enalapril |
| Title: | Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease |
| Acronym: | |
| Status: | UNKNOWN |
| Study Results: | NO |
| Results: | |
| Conditions: | Kidney Failure, Chronic|Cardiovascular Diseases |
| Interventions: | DRUG: Candesartan and enalapril|DRUG: candesartan and enalapril|DRUG: candesartan and enalapril|DRUG: candesartan and enalapril |
| Outcome Measures: | Primary: pulse wave velocity (aortic and brachial), 0, 8, 16 and 24 weeks after start of intervention | Secondary: augmentation index, 0, 8, 16 and 24 weeks after start of intervention|blood pressure (brachial and aortic), 0, 8, 16 and 24 weeks after start of intervention|buckbergs index, 0, 8, 16 and 24 weeks after start of interven|time to reflection, 0, 8, 16 and 24 weeks after start of interven|pulse pressure, 0, 8, 16 and 24 weeks after start of interven|change in glomerular filtration rate (GFR), 0, 8, 16 and 24 weeks after start of interven|blood parameters, at start of intervention and after each 2.5 - 3.week in the study period |
| Sponsor/Collaborators: | Sponsor: Herlev Hospital |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 60 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2005-09 |
| Completion Date: | |
| Results First Posted: | |
| Last Update Posted: | 2009-01-19 |
| Locations: | Dept. of Nephrology, Herlev University Hospital, Herlev, 2730, Denmark |
| URL: | https://clinicaltrials.gov/show/NCT00235287 |
